OCR Improving the health, welfare and prosperity of the global community. $ 873 m venture capital investment (in the last 5 years ) 48 venture-backed companies spun out (in the last 5 years ) 1367 active patents worldwide (as of 2020) 4th IPO (4 years straight ) 38 SRA/CRAs resulting in $17M in NEW FUNDING (in 2020) Have an Idea? Talk to OCR Faculty Industry Students OCR Programs The Fund seeks to support innovative, investigator-initiated research The Summit brings together innovators, industry & venture investment firms. Where the top biotech opportunities within Yale take the stage to present to industry Helping women extend the impact of their scientific research into the real world. Programs and resources to guide Yale faculty & grad students in entrepreneurial pursuits OCR Events Yale Innovation Summit - Day 1 May 18th, 20211:00 PM — 3:30 PM Virtual Pitch Day 1 (BioTech: Pharmaceuticals & Biotherapeutics) 8-10 industry judges 12 pitches over 2 Register here! Yale Innovation Summit - Day 2 May 19th, 20211:00 PM — 3:30 PM Virtual Pitch Day 2 (Tech: MedTech, Digital Health, Engineering & Software, Diagnostics) 8-10 industry Register here! All Events OCR News D&D Pharmatech Announces Sponsored Research Agreement with Yale University to Optimize Novel Strategies for the Treatment of Brain Cancer and Other Diseases of the Central Nervous System Read story Next Story The 2021 Yale Innovation Summit agenda has been announced! Read story Next Story Qx Therapeutics Inc. has received U.S. Food and Drug Administration authorization of “safe to proceed” with investigating QXT-101 in a Phase 2 Clinical Trial for Patients with Severe Symptomatic COVID-19 Infection. Qx Therapeutics Inc., a pharmaceutical company focusing on novel treatments for lung injury and Read story Next Story Sylvia McBrinn, M.B.A. Named Yale Entrepreneur-in-Residence Sylvia McBrinn, M.B.A., is currently an angel investor with ReNetX Bio, a Yale spinout based on Read story Next Story All News
Yale Innovation Summit - Day 1 May 18th, 20211:00 PM — 3:30 PM Virtual Pitch Day 1 (BioTech: Pharmaceuticals & Biotherapeutics) 8-10 industry judges 12 pitches over 2 Register here!
Yale Innovation Summit - Day 2 May 19th, 20211:00 PM — 3:30 PM Virtual Pitch Day 2 (Tech: MedTech, Digital Health, Engineering & Software, Diagnostics) 8-10 industry Register here!
D&D Pharmatech Announces Sponsored Research Agreement with Yale University to Optimize Novel Strategies for the Treatment of Brain Cancer and Other Diseases of the Central Nervous System Read story Next Story
Qx Therapeutics Inc. has received U.S. Food and Drug Administration authorization of “safe to proceed” with investigating QXT-101 in a Phase 2 Clinical Trial for Patients with Severe Symptomatic COVID-19 Infection. Qx Therapeutics Inc., a pharmaceutical company focusing on novel treatments for lung injury and Read story Next Story
Sylvia McBrinn, M.B.A. Named Yale Entrepreneur-in-Residence Sylvia McBrinn, M.B.A., is currently an angel investor with ReNetX Bio, a Yale spinout based on Read story Next Story
